We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Paper-Based TB Test Could Increase Diagnoses Worldwide

By LabMedica International staff writers
Posted on 26 Sep 2017
Print article
Image: Scientists have developed a rapid, paper-based TB text that allows results to be read with a smartphone (Photo courtesy of Wikimedia Commons).
Image: Scientists have developed a rapid, paper-based TB text that allows results to be read with a smartphone (Photo courtesy of Wikimedia Commons).
In resource-limited areas, equipment requirements and long wait times for results are obstacles to early diagnosis and treatment of tuberculosis (TB). To tackle this problem, scientists have developed a rapid colorimetric TB assay using gold nanoparticles on a paper-based device than enables results to be read with a smartphone.

Most of deaths from TB occur in low- and middle-income countries and remote areas. Conventional methods such as sputum smear microscopy, chest X-rays, and molecular-based tests require equipment, electricity, and specialized personnel. So lead researcher Chien-Fu Chen, professor at National Taiwan University (Taiwan), and colleagues from Chang Gung Memorial Hospital (Taiwan) and elsewhere in Taiwan, set out to come up with a more practical diagnostic test that can be read with a smartphone, a technology that is becoming increasingly available in emerging economies.

The researchers combined gold nanoparticles with single-stranded DNA (ssDNA) sequences that bind to the genetic material of Mycobacterium tuberculosis. These nanoparticles were then incorporated into a paper-based device. Adding even a minute amount of lab-derived, double-stranded DNA (dsDNS) from M. tuberculosis changed the color of the test spots within an hour. Furthermore, multiple tests could be performed simultaneously with a 60 min turnaround time.

A smartphone camera was used to analyze the color change to determine the bacterial concentration. The researchers also tested a tissue sample from an infected patient to further demonstrate that the device could be used in the field.

The study, by Tsai TT et al, was published September 13, 2017, in the journal ACS Sensors.

Related Links:
National Taiwan University
Chang Gung Memorial Hospital

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: The utilization of liquid biopsies in cancer research is a rapidly developing field (Photo courtesy of Lightspring/Shutterstock)

Blood Samples Enhance B-Cell Lymphoma Diagnostics and Prognosis

B-cell lymphoma is the predominant form of cancer affecting the lymphatic system, with about 30% of patients with aggressive forms of this disease experiencing relapse. Currently, the disease’s risk assessment... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The Sampler device could revolutionize sample collection for diagnostic tests (Photo courtesy of ReadyGo Diagnostics)

First of Its Kind Universal Tool to Revolutionize Sample Collection for Diagnostic Tests

The COVID pandemic has dramatically reshaped the perception of diagnostics. Post the pandemic, a groundbreaking device that combines sample collection and processing into a single, easy-to-use disposable... Read more